Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 172.5
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Delta Asia International Corporation manufactures and sells medical device parts and final products in Taiwan. The company was founded in 2004 and is based in Taoyuan City, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA
Data is available to registered users only
Buy
Sell